Trial record 8 of 39 for:
Open Studies | "Xerostomia"
Lipid Based Food Additives for Treating Patients With Dry Mouth
The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2006 by Hadassah Medical Organization.
Recruitment status was Not yet recruiting
Recruitment status was Not yet recruiting
Sponsor:
Hadassah Medical Organization
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00422370
First received: December 14, 2006
Last updated: January 16, 2007
Last verified: December 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Over 10% of adult population suffers from dry mouth (xerostomia). The aim of this double blind prospective clinical trial is to examine a new lipid based food additive formulation to ease mouth dryness in these patients.
| Condition | Intervention |
|---|---|
|
Xerostomia |
Device: lipid based additives based on vegetable oil & lecithin |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double-Blind |
| Official Title: | Lipid Based Food Additives for Treating Patients With Dry Mouth |
Resource links provided by NLM:
Further study details as provided by Hadassah Medical Organization:
Eligibility| Ages Eligible for Study: | 18 Years to 90 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Dry mouth patients
Exclusion Criteria:
- Disabled patients
- Pregnant
- Full upper denture
- Under 18 years old
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00422370
Contacts
| Contact: Doron J Aframian, DMD PhD | 0097226776151 | daframian@yahoo.com |
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
| Study Chair: | Doron J Aframian, DMD PhD | Reference: Kelly HM et al. Bioadhesive,rheological, lubricant and other aspectes of an oral gel formulation intended for the treatment of xerostomia. Int J Phramac. 2004; 278: 391-406 |
| Study Chair: | Doron J Aframian, DMD PhD | Salivary Gland Clinic, Department of Oral Medicine The Hebrew University-Hadassah School of Dental Medicine Jerusalem, Israel P.O.B 12272, Zip code 91120 |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00422370 History of Changes |
| Other Study ID Numbers: | 38-29.12.06 |
| Study First Received: | December 14, 2006 |
| Last Updated: | January 16, 2007 |
| Health Authority: | Israel: Health Department |
Additional relevant MeSH terms:
|
Xerostomia Salivary Gland Diseases Mouth Diseases Stomatognathic Diseases |
ClinicalTrials.gov processed this record on May 19, 2013